Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moehs Catalana is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) and a core component of the Moehs Group. Located in Rubí, Spain, the company focuses on the chemical synthesis of small molecule APIs for a diverse range of therapeutic applications, including treatment for cardiovascular and central nervous system disorders. As a Contract Development and Manufacturing Organization (CDMO), Moehs Catalana provides services ranging from process development to large-scale commercial production under strict cGMP compliance. The facility is regularly inspected by international regulatory bodies, including the FDA and EMA, ensuring high-quality standards for the global market. Since 2004, the company has been a subsidiary of the American multinational conglomerate PMC Global.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moehs Catalana.